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Objective: To assess the effects of hot water leaf extract of Nauclea latifolia
(N. latifolia) on antioxidant status, lipid peroxidation values and parasite levels in hepatic
and brain tissue of experimental mice (BALB/c) infected with Plasmodium berghei
(P. berghei) malaria.
Methods: Forty nine mice were divided into seven groups (n = 7) and used for the study.
Group A (control) were given 0.2 mL/kg phosphate buffer saline; Group B mice were
infected with P. berghei and treated with phosphate buffer saline. Groups C and D mice
were also infected but treated with 200 and 300 mg/kg body weight of leaf extract
respectively. Groups E and F mice were not infected, but received 200 and 300 mg/kg of
leaf extract respectively. Group G mice were infected and treated with chloroquine (5 mg/
kg). Liver and brain tissues of mice were prepared for both biochemical assay and
microscopic examination.
Results: Results showed that P. berghei malaria infection induced oxidative stress in
both liver and brain tissues as evidenced by the signiﬁcant (P < 0.05) decrease in anti-
oxidants: superoxide dismutase, reduced glutathione and catalase. These reductions
perhaps caused compromise in membrane integrity as indicated by the signiﬁcant increase
in lipid peroxidation product malondialdhyde. Malaria parasites were also identiﬁed in
these tissues. However, N. latifolia treatment eliminated the parasites in tissues and
protected them from oxidative damage even better than chloroquine treatment did, whose
anti-malarial potency also cleared tissue parasites. The measurement of protection by
N. latifolia against damage was strengthened by the insigniﬁcant micro structural
alterations.
Conclusions: The bioactive phytochemical(s) in N. latifolia should be structured and the
mechanism(s) of its antimalarial tendency should be further investigated.1. Introduction
Malaria remains a devastating global health problem and a
major health burden especially for the developing countries [1,2].
Malaria is known as the world's most important tropical
infectious disease in humans, which infects about 300–500
million people worldwide and is accountable for 1–3 million
deaths annually [3,4].Malaria infection decreases the levels of antioxidant enzymes
[catalase (CAT), superoxide dismutase (SOD)] and reduced
glutathione (GSH) system as well as cholesterol and other lipids
like triacylglycerol. The degree of severity of malaria is directly
proportional to the level of lipid peroxidation [5], an indication of
membrane damage prior to oxidative stress. In the brain, nervous
system gets involved predominantly in Plasmodium falciparum
malaria causing increased cytoadherence and resetting of red
cells by sequestration of parasitized red blood cells in the
cerebral microvasculature that enhances vessel occlusion,
hypoxia, endothelial activation and blood–brain–barrier
dysfunction [6].
Nauclea latifolia (N. latifolia) (family: Rubiaceae) locally
nicknamed chloroquine leaf is an evergreen multi-stemmedn open access article under the CC BY-NC-ND
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head’, it is a struggling shrub or small tree native to tropical
Africa and Asia [7]. All parts of the plant, the leaves, stem, stem
bark and roots are a rich source of monoterpene indole alkaloids.
In most parts of the African countries including Nigeria, the
plant's stem, bark, root and leaves are used in treatment of
malarial infection [8]. The effect of N. latifolia such as
lowering blood pressure, antidiabetic, anticonvulsant,
antipyretic, analgesic, anxiolytic and sedative properties have
been reported [7,9–11]. Nevertheless, the ability of N. latifolia
leaf extract to eliminate both hepatic and cerebral malarial
parasite and reduce oxidative damage to tissues in
Plasmodium berghei (P. berghei) infected mice is yet to be
experimentally documented. Hence, the present study was
conducted to evaluate the effects of hot water leaf extract of
N. latifolia on antioxidant status, lipid peroxidation values and
parasite levels in hepatic and brain tissue of experimental mice
(BALB/c) infected with P. berghei malaria.
2. Materials and methods
2.1. Harvesting of leaf extract
N. latifolia fresh leaves were harvested from Abraka com-
munity in Delta State of Nigeria. The plant was identiﬁed at the
Nigerian Institute of Forestry Research, Ibadan, Oyo State and
classiﬁed as N. latifolia, belonging to the Rubiaceae family.
2.2. Preparation of leaf extract
The aqueous extract of the leaf (N. latifolia) was obtained by
boiling 50 g of the fresh leaf in 1000 mL of water for about
10 min under standard atmospheric pressure (760 mmHg). It was
allowed to cool before administered to the experimental animals.
2.3. Experimental animals
Forty-nine adults albino male (BALB/c) mice (sixteen weeks
old) weighing between 15 and 25 g were obtained from the
Animal House, Faculty of Basic Medical Sciences, Delta State
University, Abraka, Nigeria. The mice were fed with growers’
marsh feed (a product of Top-Feeds, Sapele, Delta State,
Nigeria) and given water ad libidum. The animals were housed
in cages constructed of stainless steel and plastic under control
condition of 12 h:12 h light:dark cycle. The animals used in this
study were maintained in accordance with the guidelines as
stated in the guide for the care and use of laboratory animals [12].
2.4. Inoculation of experimental animals
One P. berghei parasitized mouse was obtained from the
Nigerian Institute of Medical Research, Yaba, Lagos State,
Nigeria. About 0.1 mL of infected blood was collected from the
parasitized mouse and diluted with 0.9 mL phosphate buffer (pH
7.2). Twenty-eight mice were inoculated intraperitoneally with
0.1 mL parasitized suspension.
2.5. Animal experimental groups
The 49 mice (21 normal mice and 28 surviving parasitized
mice) were divided into 7 groups with 7 mice each as follows:Group A: non-parasitized mice + 0.2 mL/kg body weight of
phosphate buffered saline (PBS); Group B: parasitized
mice + 0.2 mL/kg body weight of PBS; Group C: parasitized
mice + 200 mg/kg body weight of N. latifolia; Group D: Parasit-
ized mice + 300 mg/kg body weight ofN. latifolia; Group E: non-
parasitizedmice +200mg/kg bodyweight ofN. latifolia; GroupF:
non-parasitized mice + 300 mg/kg body weight of N. latifolia;
GroupG: parasitized mice + 5mg/kg body weight of chloroquine.
The N. latifolia leaf extract and chloroquine were adminis-
tered for ﬁve days by oral gavage.
2.6. Animal sacriﬁce and collection of specimen
On the 6th day, mice were fasted overnight and sacriﬁced
under anaesthesia (chloroform soaked in cotton wool), and tis-
sues (brain and liver) were excised, refrigerated until needed for
biochemical estimation.
2.7. Preparation of tissue homogenate
One gram of frozen tissues (brain or liver) was homogenized
in 9 mL of cold normal saline and centrifuged at 3500 r/min for
20 min. The supernatant obtained was decanted and used for the
biochemical assay.
2.8. Analysis of specimens
The brain and liver malondialdehyde (MDA) levels were
determined using the method of Buege and Aust [13]. Reduced
GSH was assayed using the method of Ellman [14]. The
antioxidant enzymes SOD and CAT were estimated using the
methods of Misra and Fridovich [15], and Kaplan and Groves
[16], respectively.
2.9. The histopathological analysis
Liver and brain tissue samples were immediately collected
and ﬁxed in 10% buffered formaldehyde solution for a period of
at least 24 h before histopathological study. Samples were then
embedded in parafﬁn wax and 5 mm thick sections were pre-
pared with a microtome. These thin sections were stained with
haematoxylin and eosin, mounted on glass slides with Canada
balsam (Sigma, USA) and observed for pathological changes
under a binocular microscope.
2.10. Statistical analysis
The data obtained were subjected to One–way analysis of
variance (ANOVA) and Duncan's multiple range test. Values
were considered statistically different at 5% probability level.
All statistical analyses were performed using SPSS version 16.
3. Results
The results obtained are presented in Tables 1 and 2 and
Figures 1–14. Table 1 shows the changes in brain lipid peroxi-
dation marker MDA and antioxidants like reduced GSH, SOD
and CAT induced by P. berghei malarial infection and the effect
of N. latifolia.
The biochemical values (Table 1) showed that P. berghei
malarial infection (Group B) signiﬁcantly (P < 0.05) reduced
Table 2
Changes in liver MDA, GSH, SOD and CAT activities in both parasitized













A 0.24 ± 0.02a 2.02 ± 0.22a 11.56 ± 2.56a 18.92 ± 3.77a
B 0.53 ± 0.02b 1.59 ± 0.19b 27.54 ± 3.57b 13.92 ± 3.92b
C 0.48 ± 0.03c 2.52 ± 0.34c 22.24 ± 4.18c 16.42 ± 4.22c
D 0.48 ± 0.03c 2.65 ± 0.24c 14.85 ± 3.61d 16.04 ± 3.96c
E 0.39 ± 0.02d 1.84 ± 0.17d 13.42 ± 3.11d 19.84 ± 4.11d
F 0.40 ± 0.03d 1.89 ± 0.22d 12.58 ± 2.96d 21.93 ± 4.26e
G 0.42 ± 0.03c 2.38 ± 0.30e 18.58 ± 3.29e 17.09 ± 3.92f
Values are presented as mean ± SD. Means not bearing same superscript
alphabet in a given vertical column differs signiﬁcantly at P < 0.05.
Figure 2. Brain tissue of mice inoculated with P. berghei for 5 d.
A: Mild vascular congestion and clogging with parasites; B: Mild tissue
separation (H&E, × 40).
Figure 3. Brain tissue of mice inoculated with P. berghei and treated with
200 mg/kg N. latifolia for 5 d.
A: Mild inﬁltrates of lymphocytes; B: Microglial hyperplasia; C: Mild
tissue separation (H&E, × 40).
Table 1
Changes in brain peroxidation product (MDA) and antioxidants (SOD,













A 0.26 ± 0.06a 2.22 ± 0.48a 3.26 ± 0.72a 50.66 ± 5.32a
B 0.33 ± 0.08b 1.24 ± 0.52b 21.17 ± 3.24b 37.12 ± 3.83b
C 0.22 ± 0.09c 2.32 ± 0.42a 16.52 ± 3.46c 39.33 ± 4.01b
D 0.22 ± 0.04c 2.54 ± 0.42a 15.95 ± 3.12c 42.85 ± 4.75c
E 0.26 ± 0.07a 2.36 ± 0.35a 2.54 ± 0.83a 46.38 ± 3.55c
F 0.27 ± 0.05a 2.62 ± 0.52a 4.24 ± 1.02d 53.09 ± 6.36a
G 0.27 ± 0.06a 1.64 ± 0.25c 5.88 ± 1.22e 26.03 ± 3.11d
Values are presented as mean ± SD. Means not bearing same superscript
alphabet in a given vertical column differs signiﬁcantly at P < 0.05.
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increased (P < 0.05) SOD value when compared with the non-
parasitized (Group A) control mice. These changes produced
signiﬁcant amount of lipid peroxidation product (MDA), an
indication of enhanced membrane lipid damage among the
parasitized mice. The two doses of N. latifolia (Groups C and
D) had increased GSH levels and CAT activity, but reduced
SOD when compared with the values for the placebo (PBS)
treated parasitzed group (Group B), resulting in reduced
(P < 0.05) lipid peroxidation product. When compared with
200 and 300 mg/kg body weight N. latifolia treatment (GroupsFigure 1. Brain tissue of normal rat (control).
A: Cerebral blood vessel; B: Nucleus of neural cell bodies; C: Axon ﬁbrils
(H&E, × 40).
Figure 4. Brain tissue of mice inoculated with P. berghei and treated with
300 mg/kg N. latifolia for 5 d.
A: Mild inﬁltrates of lymphocytes; B: Microglial hyperplasia; C: Mild
tissue separation; D: Mild vascular dilatation (H&E, × 40).
Figure 5. Brain tissue of mice treated with 200 mg/kg N. latifolia for 5 d.
A: Mild inﬁltrates of lymphocytes; B: Microglia hyperplasia (H&E, × 40).
Figure 8. Liver tissue of normal mice (control).
A: Portal triad; B: Hepatocytes; C: Separated by sinusoids (H&E, × 40).
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and increased MDA level. GSH and CAT may have better
protective ability than SOD does against malaria-induced
membrane lipid peroxidation and oxidative brain damage.Figure 6. Brain tissue of mice treated with 300 mg/kg N. latifolia for 5 d.
A: Mild inﬁltrates of lymphocytes; B: Microglia hyperplasia; C: Mild tissue
separation (H&E, × 40).
Figure 7. Brain tissue of mice inoculated with P. berghei and treated with
standard doses of chloroquine for 5 d.
A: Mild inﬁltrates of lymphocytes; B: Microglia hyperplasia; C: Mild
vascular congestion and dilatation; D: Mild tissue separation (H&E, × 40).
Figure 9. Liver tissue of mice inoculated with P. berghei for 5 d.
A: Mild portal congestion and clogging with parasites; B: Mild hyperplasia
of haemosiderin laden kupffer cells; C: Mild periportal inﬁltrates of in-
ﬂammatory cells (H&E, × 40).
Figure 10. Liver tissue of mice inoculated with P. berghei and treated with
200 mg/kg N. latifolia for 5 d.
A: Mild portal congestion; B: Moderated hyperplasia of haemosiderin laden
kupffer cells; C: Mild periportal inﬁltrates of inﬂammatory cells
(H&E, × 40).
Figure 11. Liver tissue of mice inoculated with P. berghei and treated with
300 mg/kg N. latifolia for 5 d.
A: Mild portal congestion; B: Moderate hyperplasia of haemosidrin laden
kupffer cells; C: Mild periportal inﬁltrates of inﬂammatory cells; D:
Increased number of hepatocytes (H&E, × 40).
Figure 12. Liver tissue of mice treated with 200 mg/kg N. latifolia for 5 d.
A: Mild portal congestion and dilatation; B: Hepatocytes with nuclei con-
taining numerous inconspicuous nucleoli (H&E, × 40).
Figure 13. Liver tissue of mice given 300 mg/kg N. latifolia for 5 d.
A: Mild portal congestion and dilatation; B: Hepatocytes with nuclei con-
taining numerous inconspicucous nucleoli (H&E, × 40).
Figure 14. Liver tissue of mice treated with standard doses of chloroquine
after inoculation for 5 d.
A: Moderate portal congestion and dilatation portal congestion and dila-
tation; B: Hepatocytes with nuclei containing numerous inconspicuous
nucleoli; C: Mild periportal inﬁltrates of inﬂammatory cells (H&E, × 40).
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higher defense to oxidative damage in the brain than chloro-
quine does.
Table 2 contains data on the changes in liver MDA, GSH,
SOD and CAT activities induced by choloquine sensitive
P. berghei malarial parasite and the effect of treatment with
N. latifolia leaf extract.
In the liver, the trends in changes of the lipid membrane
peroxidation marker MDA and antioxidants (GSH, SOD and
CAT) activities were similar to the observation for the brain.
P. berghei infection reduced both hepatic GSH and CAT ac-
tivities (P < 0.05) when compared with the non-parasitized
control group (Group A), and these changes resulted in lipid
membrane damage as indicated by the signiﬁcant increase in
MDA value.
However, N. latifolia and choloroquine treatments (Groups
C, D and G) increased GSH and CAT activities, but reduced
SOD activity when compared with the parasitized group treated
with PBS (Group B). The increase in GSH concentration and
CAT activity as observed reduced the level of peroxidation
(MDA estimation) in both N. latifolia and chloroquine treated
mice (Groups C, D and G) compared with Group B, but this
reduction was signiﬁcantly higher than that observed in com-
parision of Groups C, D and G, and the control mice (Group A).
Figures 1–14 show the histopathological microstructure of
the brain (Figures 1–7 for Groups A-G) and liver (Figures 8–14
for Groups A-G).
Mice infected with P. berghei showed parasites in both liver
and brain tissues in addition to signiﬁcant microstructural al-
terations indicative of damage. N. latifolia and chloroquine
treatments eliminated both liver and brain parasites and miti-
gated the microstructural alteration and damage caused by
P. berghei.
4. Discussion
Malaria is an endemic parasitic infection in Africa and re-
mains a contributory factor to the morbidity and mortality of
many populations in the world with about 3.3 billion people at
risk of malaria, and the mortality caused by malaria is currently
estimated at about 781 000 people per year [17,18]. Malaria is
associated with increased production of free radicals.
Biological system protect itself against the damaging effect of
activated species by the actions of free radical scavengers and
chain terminator antioxidant enzymes such as SOD, CAT, and
reduced GSH system [19]. Reduced GSH in conjunction with
reduced nicotinamide adenine dinucleotide phosphate protects
the cell by destroying hydrogen peroxide and hydroxyl free
radicals. Regeneration of GSH from its oxidized form GSH
disulﬁde requires the nicotinamide adenine dinucleotide
phosphate produced in the glucose 6-phosphate dehydrogenase
reaction [20]. SOD breaks up superoxide into water and
hydrogen peroxide. CAT, then breaks up the hydrogen
peroxide into water and dioxygen to prevent the hydrogen
peroxide from becoming a free radical.
The result of this study showed a higher lipid peroxidation
and also an increased level of MDA in the brain and liver of the
P. berghei parasitized mice (Group B). Administration of 200
and 300 mg/kg body weight of N. latifolia leaf extract reduced
both brain and liver MDA levels and improved antioxidant
(SOD, CAT, and GSH) defense even when compared with the
chloroquine treatment. The extract contributes to the protection
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radicals produced by the P. berghei malaria parasite possibly via
antioxidant boost; either by contributing to the induction of GSH
reductase which enhances the conversion of oxidized GSH to
GSH, and consequently increasing the blood and hepatic GSH
value in parasitized mice, or donating electrons to the free rad-
icals, thereby reducing them to a less reactive radical, or
reducing the parasites. Therefore, aqueous leaf extract of
N. latifolia could contribute to the protection against oxidative
damage in malaria and improve the antioxidant status in a dose
dependent manner.
Conﬁrming the biochemical values, results of the histo-
pathological pictures show that inoculation of mice with ma-
larial parasite P. berghei caused mild loosening of brain
tissues together with mild vascular congestion and clogging of
vessels with the parasite (parasitaemia and mild congestion).
However, treatment with N. latifolia (200 and 300 mg/kg body
weight) revealed mild congestion in the vessels, and inﬁltra-
tion of the tissue by lymphocyte and microglia; also, the
clogging of the blood vessels with parasite was not observed
and tissue loosening was negligible. With chloroquine
administration, there was mild vascular congestion and no
parasitaemia in Group G. However, the inﬁltration by lym-
phocytes and microglia cells was slightly less pronounced than
that observed in mice treated with extract. Similar trend was
observed for the liver tissue.
P. berghei malarial infection could result in a marked
depletion of host cytoprotective enzymes and antioxidants in the
brain and liver, thus elevating the levels of lipid peroxidation,
which was observed in the form of its product MDA. Treatment
of infected mice with N. latifolia aqueous leaf extract reduced
lipid peroxidation and oxidative stress, by probably improving
antioxidant defense.
Since aqueous leaf extract of N. latifolia appears promising,
it's potency in antiplasmodial and antioxidant activities need to
be further exploited.
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